| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Johns Hopkins Oncology Center [J. T. I., D. S. C.] and Department of Urology [J. T. I., D. S. C.], The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, and Departments of Genetics and Endocrinology, Roswell Park Memorial Institute, Buffalo, New York 14263 [N. W., A. A. S.]
The androgen-sensitive Dunning R-3327-H prostatic adenocarcinoma has been maintained by continuous serial passage in intact male rats for many years. While it has been possible to maintain the original characteristics of the well-differentiated H tumor over 16 years, there have evolved spontaneously, however, more aberrant sublines from this tumor at several subpassages in intact male rats. Serial passage of these individual sublines has established five additional R-3327 tumors each with distinct phenotypes and each more aberrant than the parent H tumor. In addition, it has been possible by passage of the H tumor in castrated male rats to obtain a well-differentiated slow-growing androgen-insensitive tumor termed the HI-S tumor. The continuous serial passage of this HI-S tumor has likewise resulted in the emergence of three new types of Dunning tumors. The results from the biochemical and chromosomal studies presented demonstrate that there is a consistent association in each of these tumor progressions between the expression of genetic instability, which results in the addition of phenotypically new clones of cells to the tumor population, and the subsequent selection of these newly developed clones. These results suggest that the process of genetic instability coupled to clonal selection is one mechanism for the change in tumor phenotype characteristically associated with tumor progression within this system of prostatic tumors.
1 Supported in part by Grant CA 15416-07 and in part by Grant CA 15436 from the National Cancer Institute.
2 To whom requests for reprints should be addressed.
Received 11/12/81. Accepted 2/25/82.
This article has been cited by other articles:
![]() |
A. Zoubeidi, A. Zardan, R. M. Wiedmann, J. Locke, E. Beraldi, L. Fazli, and M. E. Gleave Hsp27 Promotes Insulin-Like Growth Factor-I Survival Signaling in Prostate Cancer via p90Rsk-Dependent Phosphorylation and Inactivation of BAD Cancer Res., March 15, 2010; 70(6): 2307 - 2317. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Andreani, G. Gatti, L. Simonella, V. Rivero, and M. Maccioni Activation of Toll-like Receptor 4 on Tumor Cells In vitro Inhibits Subsequent Tumor Growth In vivo Cancer Res., November 1, 2007; 67(21): 10519 - 10527. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. V. Litvinov, D. J. Vander Griend, Y. Xu, L. Antony, S. L. Dalrymple, and J. T. Isaacs Low-Calcium Serum-Free Defined Medium Selects for Growth of Normal Prostatic Epithelial Stem Cells. Cancer Res., September 1, 2006; 66(17): 8598 - 8607. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Uzgare and J. T. Isaacs Enhanced Redundancy in Akt and Mitogen-activated Protein Kinase-induced Survival of Malignant versus Normal Prostate Epithelial Cells Cancer Res., September 1, 2004; 64(17): 6190 - 6199. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Nabi, A Seth, A K Dinda, and N P Gupta Computer based receptogram approach: an objective way of assessing immunohistochemistry of androgen receptor staining and its correlation with hormonal response in metastatic carcinoma of prostate J. Clin. Pathol., February 1, 2004; 57(2): 146 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Weeraratna, S. L. Dalrymple, J. C. Lamb, S. R. Denmeade, S. Miknyoczki, C. A. Dionne, and J. T. Isaacs Pan-trk Inhibition Decreases Metastasis and Enhances Host Survival in Experimental Models as a Result of Its Selective Induction of Apoptosis of Prostate Cancer Cells Clin. Cancer Res., August 1, 2001; 7(8): 2237 - 2245. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Isaacs Apoptosis: Translating Theory to Therapy for Prostate Cancer J Natl Cancer Inst, September 6, 2000; 92(17): 1367 - 1369. [Full Text] [PDF] |
||||
![]() |
H. Miyake, C. Nelson, P. S. Rennie, and M. E. Gleave Overexpression of Insulin-Like Growth Factor Binding Protein-5 Helps Accelerate Progression to Androgen-Independence in the Human Prostate LNCaP Tumor Model through Activation of Phosphatidylinositol 3'-Kinase Pathway Endocrinology, June 1, 2000; 141(6): 2257 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lin, J. T. White, C. Ferguson, R. Bumgarner, C. Friedman, B. Trask, W. Ellis, P. Lange, L. Hood, and P. S. Nelson PART-1: A Novel Human Prostate-specific, Androgen-regulated Gene that Maps to Chromosome 5q12 Cancer Res., February 1, 2000; 60(4): 858 - 863. [Abstract] [Full Text] |
||||
![]() |
N. Craft, C. Chhor, C. Tran, A. Belldegrun, J. DeKernion, O. N. Witte, J. Said, R. E. Reiter, and C. L. Sawyers Evidence for Clonal Outgrowth of Androgen-independent Prostate Cancer Cells from Androgen-dependent Tumors through a Two-Step Process Cancer Res., October 1, 1999; 59(19): 5030 - 5036. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-F. Lin, T.-C. Meng, P. S. Rao, C. Chang, A. H. Schonthal, and F.-F. Lin Expression of Human Prostatic Acid Phosphatase Correlates with Androgen-stimulated Cell Proliferation in Prostate Cancer Cell Lines J. Biol. Chem., March 6, 1998; 273(10): 5939 - 5947. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |